ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Orbimed Advisors LLC bought $9.5M of Arcutis Biotherapeutics, Inc.
Director and 10% owner
Bought$9,501,096
$17.00Price
558,888Shares
What ARQT did for a copier
Prices for ARQT after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Feb 3. Filed Tue, Feb 4, 5:30 PM ET, after the close. Not investment advice.